AZ/Merck’s Lynparza approved by SMC to treat advanced prostate cancer in Scotland Up to 20% of prostate cancer cases are classified as castration-resistant
AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland The progressive neurological disorder affects approximately 12,400 people in Scotland